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 Abstract 
Background:  A pronounced tumour inflammatory infiltrate is known to confer a good 
outcome in colorectal cancer.  Klintrup and colleagues reported a structured assessment of 
the inflammatory reaction at the invasive margin scoring low or high grade.  The aim was 
to examine the prognostic value of tumour inflammatory infiltrate in node-negative 
colorectal cancer. 
Methods:  200 patients had surgery for node-negative colorectal cancer between 1997-
2004.  Specimens were scored with Jass and Klintrup criteria for peritumoural infiltrate.  
Pathological data was taken from reports at the time. 
Results:  Low-grade inflammatory infiltrate assessed using Klintrup’s criteria was an 
independent prognostic factor in node negative disease.  In patients with a low-risk 
Petersen Index (n=179), low-grade infiltrate carried a 3-fold increased risk of cancer death.  
Low-grade infiltrate was related to increasing T stage and an infiltrating margin. 
Conclusion:  Assessment of inflammatory infiltrate using Klintrup’s criteria provides 
independent prognostic information in node-negative colorectal cancer.  A high-grade local 
inflammatory response may represent effective host immune responses impeding tumour 
growth. 
 
 
Introduction 
Colorectal cancer is the second most common cause of cancer death in Western 
Europe and North America.  Each year in the UK, there are approximately 35,000 new 
cases and 16,000 deaths attributable to this disease 1.  Overall survival is poor; even in 
those who undergo resection with curative intent, only half survive five years 2.  Prognosis 
and thereby optimal treatment can be partly predicted by clinico-pathological criteria.  
Tumour stage, in terms of the extent of local spread and lymph node status, has long been 
recognised to predict outcome.  This is the basis of the Dukes’ and TNM staging systems 
which have four main categories 3 4.   
However some stages, e.g. Stage II (T3/4 N0, Dukes B) include patients with a 
wide range of clinical outcomes.  Additional clinically applicable prognostic features have 
therefore been sought.  Pathologically determined criteria which provide independent 
prognostic information following resection of node-negative colorectal cancer have been 
identified by Shepherd’s group 4.  These are: peritoneal involvement, venous spread (both 
submucosal and extramural), spread to involve a surgical margin, and perforation through 
the tumour.  The so-called Petersen prognostic index (PI) combines these four factors in a 
simple cumulative scoring system.  Patients have a worse outcome when more of these 
features are present.  Thus in lymph node negative disease, a group which makes up 40-
50% of surgical resections for colorectal cancer 6 7, 5 year survival of 75-90% is reported; 
however, where high risk pathological features are present survival is similar to node 
positive disease 8 9.  The Petersen Index can select patients at high risk of tumour 
recurrence who may benefit from adjuvant treatment and is validated in Dukes B and C 
(single positive node) colorectal cancer 5 10. 
Since the first study by Jass and colleagues 11, the presence of a pronounced tumour 
inflammatory infiltrate has also been recognised as an important determinant of good 
outcome following potentially curative resection for colorectal cancer 12 13 14.  More 
recently, Galon and co-workers 15 concluded that the type and density of immune cells in 
and around the tumour were a primary determinant of tumour progression.  However, 
assessment of the tumour inflammatory infiltrate is not routinely performed:  for example, 
presence of tumour infiltrating lymphocytes is listed as non-core data within the RCPath 
guidelines 4.  This is largely because its assessment has been perceived to be more subject 
to inter-observer variation than the standard staging and Petersen parameters 16 17.  
Recently, however, Klintrup and colleagues described a simplified method for structured 
scoring of the inflammatory reaction at the tumour invasive edge 18.  This includes all white 
cell types and results in a binary score of low-grade or high-grade. 
The aim of the present study was to examine the prognostic value of a simple 
assessment of the tumour inflammatory infiltrate in addition to routinely reported tumour 
pathological criteria including the Petersen Index in patients undergoing curative resection 
for node negative colorectal cancer.  Furthermore the prognostic value of inflammatory 
infiltrate and tumour margin characteristics in node negative disease will be examined. 
Materials and methods 
Consecutive patients with histologically proven colorectal cancer who, on the basis 
of laparotomy findings and pre-operative abdominal computed tomography, were 
considered to have undergone potentially curative resection for node-negative colorectal 
cancer (Stage I and II) between January 1997 and June 2004 in a single surgical unit at 
Glasgow Royal Infirmary, were included in the study.  Patients were identified from a 
prospectively maintained database.  Clinical conditions known to acute or chronically 
evoke a systemic inflammatory response were excluded from the present study.  These 
include (i) emergency presentation (ii) clinical evidence of infection such as pyrexia and 
elevated white cell count (iii) presence of a chronic inflammatory condition.  Patients 
receiving pre-operative radiotherapy were excluded from the study since radiotherapy has 
been reported to evoke an inflammatory response 19 20.  Patients who died within 30 days of 
surgery were excluded from the analysis.  The tumours were staged using the conventional 
Tumour, Node and Metastases classification (from the 5th edition and according to the 
Royal College of Pathologists Dataset 2007) 4.  All other pathological data were taken from 
the pathology reports issued at the time of resection.   
The routine haematoxylin and eosin slides were retrieved from the pathology 
archives.  A minimum of three slides per specimen were selected from the deepest area of 
tumour invasion and scored according to both Jass 11 and Klintrup 18 criteria.  The Klintrup 
method is based on the deepest point of invasion identified from the 3 slides and this 
provides the overall score for the specimen.   
Jass scoring of slides was carried out as described previously 11 17.  Briefly, the term 
“peritumoural lymphocytic infiltrate” was applied to the stromal response at the tumours’ 
invasive edge.  A specific and important feature of this response is the presence of a loose 
connective tissue lamina or cap (resembling lamina propria) at the deepest point of tumour 
penetration.  The tumour glands are often heavily infiltrated by neutrophils but 
lymphocytes are not necessarily present in large numbers: it is the connective tissue stroma 
which is the most important feature.  The tumours were scored on a 2-point scale as 
peritumoural infiltrate either present or absent. 
Klintrup scoring of slides was carried out as described previously 18.  Briefly, 
tumours were scored according to a 4 point score.  Scores were based on appearances at the 
deepest area of tumour invasion.  A score of 0 indicated there was no increase in 
inflammatory cells at the deepest point of the tumour’s invasive margin; score 1 denoted a 
mild and patchy increase in inflammatory cells; score 2 denoted a prominent inflammatory 
reaction forming a band at the invasive margin with some evidence of destruction of cancer 
cell islands and score 3 denoted a florid cup-like inflammatory infiltrate at the invasive 
edge with frequent destruction of cancer cell islands.  These scores were then subsequently 
classified as low-grade (scores 0 and 1) or high-grade (scores 2 and 3) (Figures 1 and 2). 
Assessment of tumour margin characteristics was also undertaken in accordance 
with Jass criteria 11 17.  Briefly, specific features of a diffusely infiltrating tumour margin 
include ‘streaming dissection’ of tumour cells through the muscularis propria, or dissection 
of mesenteric adipose tissue by small glands or irregular clusters of cords of cells on 
microscopic examination.  
A total of 100 tumour specimens were scored independently by 2 observers (CSDR 
and JMS), who were blinded to patient outcome, to confirm consistency of scoring.  
Training was provided by a consultant pathologist (KO).  The inter-observer intraclass 
correlation coefficients (ICCC) provides a measure of interobserver agreement.  The 
ICCCs for assessment of peritumoural inflammatory cell infiltrate were: 0.71 for Jass and 
0.81 for Klintrup.  For assessment of tumour margin characteristics (expanding or 
infiltrating), the ICCC was 0.83 (ICCC values of ≥ 0.6 are considered acceptable and >0.7 
is considered good).  CSDR then scored all slides (n=200) and these data were used in the 
analysis.   
The Petersen Index was generated from scores allocated to the four selected 
pathological variables present in a tumour specimen.  Intra or extramural vascular invasion, 
peritoneal involvement and surgical margin involvement were allocated a score of 1.  
Tumour perforation was allocated a score of 2.  The total score is calculated and the PI 
considered low risk where the score is 0 or 1 and high risk from 2 to 5 5 10. 
 In the Royal Infirmary, patients undergo regular follow-up (3 months, 6 months and 
then yearly to five years) with yearly CT scanning and regular colonoscopic surveillance 
until 5 years post surgery.  Information on date and cause of death was checked with that 
received by the cancer registration system and the Registrar General (Scotland).  The study 
was approved by the Research Ethics Committee, Royal Infirmary, Glasgow. 
 
Statistics 
Grouping of the variables was carried out using standard thresholds.  Univariate 
survival analysis and multivariate survival analysis with calculation of hazard ratios (HR) 
were performed using Cox’s proportional-hazards model.  A stepwise backward procedure 
was used to derive a final model of the variables that had a significant independent 
relationship with survival.  To remove a variable from the model, the corresponding P-
value had to be greater than 0.1.  Deaths up to August 2008 were included in the analysis.  
Inter-relationships between variables were assessed using contingency table analysis with 
the chi-squared test for trend as appropriate.  Because of the number of statistical 
correlations, a P value of <0.01 was considered to be significant. Analysis was performed 
using SPSS software (SPSS Inc., Chicago, IL, USA). 
Results 
Baseline clinico-pathological characteristics and relationship with cancer specific 
survival of the patients with node negative disease (n= 200) who underwent curative 
surgery for colorectal cancer are shown in Table 1.  The majority of patients were 65 or 
older (68%), were male (55%), and had colon cancer (66%).  Eighteen (9%) patients 
received adjuvant chemotherapy.  Median number of lymph nodes sampled was 14 (range 
1-41) for colonic tumours and 12 (range 1-41) for rectal tumours.  62% of patients had 
twelve or more lymph nodes harvested (Table 1).   Overall the mean number of lymph 
nodes sampled was 14, the frequency of extramural venous invasion was 24% and serosal 
involvement was 22%, in line with current audit standards set by the Royal College of 
Pathologists 4. 
On routine pathological analysis, the minority of patients had evidence of the ‘high-
risk’ pathological features including poor tumour differentiation (9%), extramural vascular 
invasion (24%), peritoneal involvement (22%), margin involvement (8%), tumour 
perforation (3%) or perineural invasion (8%).  The minority of patients were thus classed as 
low risk by the Petersen Index (11%).  On assessment by Jass’ criteria, 61% (n=121) had 
tumour margins classed as expanding and the majority (74%, n=148) had no peritumoural 
inflammatory infiltrate.  On assessment using Klintrup’s criteria, 59% (n=118) patients 
were given scores of 0 or 1 (low grade inflammation) and 41% (n=82) were given scores of 
2 or 3 (high grade inflammation). 
The minimum follow-up was 43 months; the median follow-up of the survivors was 
73 months.  No patients were lost to follow up.  During this period 76 patients died, 36 of 
their cancer.  On univariate survival analysis of individual variables, age (P<0.01), fewer 
than 12 nodes sampled (P<0.1), vascular invasion (P<0.01), peritoneal involvement 
(P<0.1), tumour perforation (P=0.05), presence of an infiltrating invasive tumour margin 
(P<0.05) and absent or low grade peritumoural inflammatory infiltrate score assessed by 
Klintrup’s criteria (P<0.05) were associated significantly with cancer-specific survival 
(Table 1).   
On multivariate survival analysis of significant variables for cancer-specific 
survival, age (HR 2.26, 95% CI 1.42-3.61, P=0.001), high risk Petersen Index (HR 2.45, 
95% CI 1.08-5.45, P=0.032), perineural invasion (HR 3.62, 95% CI 1.48-8.89, P=0.005) 
and a low-grade peritumoural inflammatory infiltrate assessed by Klintrup’s criteria (HR 
2.61, 95% CI 1.19-5.77, P=0.017) were all independently associated with cancer specific 
survival (Table 1).   
179 patients with node-negative colorectal cancer were classed as low risk by the 
Petersen Index.  In this group, on univariate survival analysis of individual variables, age 
(P<0.001), poor tumour differentiation, (P<0.1), perineural invasion (P<0.05), presence of 
an infiltrating invasive margin (P<0.1) and absent or low grade peritumoural inflammatory 
infiltrate score assessed by Klintrup’s criteria (P<0.05) were associated with cancer-
specific survival (Table 2).   
On multivariate survival analysis for cancer-specific survival in the low risk 
Petersen Index group, age (HR 2.31, 95% CI 1.37-3.89, P=0.002), perineural invasion (HR 
3.55, 95% CI 1.20-10.55, P=0.022) and a low-grade peritumoural inflammatory infiltrate 
assessed by Klintrup’s criteria (HR 3.04, 95% CI 1.22-7.58, P=0.017) were all 
independently associated with cancer specific survival (Table 2).   
When those patients who received adjuvant chemotherapy were removed the from 
analysis, age (P<0.1), less than 12 nodes sampled (P<0.1), poor tumour differentiation 
(P<0.05), vascular invasion (P<0.05), a high risk Petersen Index (P<0.1), perineural 
invasion (P<0.005), an infiltrating tumour margin (P<0.1), and low-grade peritumoural 
inflammatory infiltrate assessed by Klintrup’s criteria (P<0.05) were associated with cancer 
specific survival on univariate analysis.  On multivariate analysis of these significant 
variables in patients who did not receive adjuvant chemotherapy, only age (HR 1.81, 95% 
CI 1.14-2.88, P=0.011) and low-grade peritumoural inflammatory infiltrate assessed by 
Klintrup’s criteria (HR 2.46, 95% CI 1.10-5.48, P=0.028) were independently associated 
with cancer specific survival.    
The inter-relationships between the individual pathological criteria in the low risk 
Petersen Index group (n=179) are shown in Table 3.  Increasing T stage was directly 
related to the presence of peritoneal involvement (P<0.001), an infiltrating tumour growth 
pattern and a low-grade peritumoural infiltrate assessed by both Jass (P<0.01) and Klintrup 
criteria (P<0.01).  A lymph node sample less than 12 was directly related to the presence of 
peritoneal involvement (P<0.01).  The presence of vascular invasion was directly 
associated with presence of perineural invasion (P<0.001).  Peritoneal involvement was 
directly associated with an infiltrating tumour growth pattern (P<0.01).  The presence of an 
infiltrating tumour growth pattern was associated with a low-grade inflammatory cell 
infiltrate assessed with Jass (P=0.001) and Klintrup criteria (P<0.001).  Both Jass and 
Klintrup criteria were directly associated (P<0.001) 
 
Discussion 
Following potentially curative resection for colorectal cancer there are a number of 
pathological features which guide treatment.  Principal among these is nodal disease which 
indicates a high likelihood of disease recurrence and the need for adjuvant therapy 3 21.  In 
patients with no evidence of nodal disease, other pathological criteria have been proposed 
by Shepherd’s group which identify patients at high risk of recurrence and which are now 
routinely reported 5.  These include vascular invasion, peritoneal involvement, margin 
involvement and tumour perforation.  These criteria have been combined in a score, the 
Petersen Index (PI), which reliably predicts poorer cancer-specific outcome in Dukes’ B 
colon cancer 5.  These findings have recently been validated in colorectal cancer by 
Quirke’s group 10. 
In the present study of patients with node-negative colorectal cancer we have 
confirmed the finding that a high risk PI is associated with poorer cancer specific survival.  
However, the majority of patients (89%) were identified by the PI as low risk.  Therefore it 
was of interest that the presence of a low-grade tumour inflammatory cell infiltrate 
(Klintrup criteria) was associated with an approximately 3-fold poorer cancer specific 
survival in these low-risk patients.  In the present study, tumour inflammatory cell infiltrate 
assessed using Jass criteria was also examined.  However, in terms of predicting cancer 
specific survival, the Klintrup criteria were superior to that of Jass.  Taken together these 
results would suggest that tumour inflammatory cell infiltrate, in particular using Klintrup 
criteria, should be considered for inclusion in routine pathological reporting of colorectal 
cancer. 
In the present study it was interest that both Jass and Klintrup criteria were 
inversely associated with T stage and an infiltrating tumour margin.  The presence of 
infiltrating growth pattern appears to be similar to the phenomenon known as de-
differentiation, where there is a dissociation of tumour cells at the invasive front allowing 
these cells to migrate away from the main tumour, which may represent a morphological 
assessment of ‘tumour aggressiveness’ 22.  This feature has also recently been described as 
‘tumour budding’ where there is a transition from glandular structures to single cells or 
clusters of up to four cells the invasive margin of colorectal tumours 23.  A high-grade local 
immune response may represent effective host cellular immune responses preventing the 
invasive margin from developing an infiltrating or budding appearance.  These results are 
consistent with the detailed analysis of the tumour immune response in patients with 
colorectal cancer by Nielsen and co-workers 13 and Galon and co-workers 15.  Furthermore, 
the results of the present study are consistent with the concept that the type, density, and 
location of a variety of immune cells, and not an individual immune cell type, is an 
important independent determinant of cancer specific survival in patients with colorectal 
cancer.  
The Klintrup method used in the present study differs from previous methods of 
assessing immune cells within the tumour as it is a structured assessment of all white cell 
types at the invasive margin.  The technique can be applied to routine H&E specimens with 
no special staining required.  Previous assessments of peritumoural inflammation have 
been criticised for the subjective nature of the scoring methodology 16 17.  In the present 
study the simple scoring method described by Klintrup was applied with relative ease and, 
as the low inter-observer variation demonstrates, it is reproducible.  In the present study, 
Klintrup’s scoring was undertaken using the original 4-point method, subsequently 
modified to a 2-point score (high and low grade) (Figures 1 and 2).  This methodology was 
similar to the original Klintrup study and we would recommend a similar method be 
applied when classifying tumours in future studies.  
With the introduction of whole population screening for colorectal cancer, earlier 
diagnosis should result in a higher proportion of early stage or node negative disease being 
treated by clinicians.  Therefore, the identification of high-risk pathological features in this 
cohort will be important in guiding provision of adjuvant therapy.  The results of the 
present study have demonstrated that in addition to existing routinely reported pathological 
features, other criteria such as low-grade peritumoural inflammation and the presence of an 
infiltrating tumour margin (which are currently listed in the Royal College of Pathologists 
guidelines but as non-core data items) are significantly related to poor survival.  These 
criteria may therefore provide additional prognostic information, which could be used to 
inform multidisciplinary teams on treatment decisions.  Currently, it is not known whether 
patients with pathological features such as low-grade inflammatory cell infiltrate would 
benefit adjuvant systemic treatment; however the same is true of other criteria such as 
vascular invasion and poor tumour differentiation 9 24.  Which patients benefit from 
adjuvant therapy may become clearer as large adjuvant chemotherapy trials publish further 
results.   
In summary, assessment of peritumoural inflammatory cell infiltrate provides 
independent prognostic information in node negative disease and should therefore be 
considered for future inclusion in routine pathological reporting of colorectal cancer.  
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 Figure 1:  Low grade inflammatory cell infiltrate at the tumours invasive edge.   
 
 
Figure 2:  High grade inflammatory cell infiltrate at the tumours invasive edge.   
Table 1:  The relationship between clinico-pathological variables and cancer specific 
survival in patients undergoing curative surgery for node-negative colorectal cancer. 
 
 
 
Patients 
n=200 (%) 
Univariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Multivariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Age  <65 years 
        65-74years 
        >75years 
64 (32) 
70 (35) 
66 (33) 
 
 
1.92 (1.24-2.98) 
 
 
0.004 
 
 
2.26 (1.42-3.61) 
 
 
0.001 
Sex  female 
        Male 
90 (45)  
110 (55) 
 
0.86 (0.45-1.66) 
 
0.659 
 
 
 
 
Site  Colon  
        Rectum 
132 (66) 
68 (34) 
 
0.75 (0.36-1.55) 
 
0.437 
  
Number of nodes harvested 
                                 >12 
                                 <12 
 
123 (62) 
77 (38) 
 
 
1.88 (0.97-3.62) 
 
 
0.060 
 
 
 
 
 
0.134 
T Stage         T1 
                     T2 
                     T3 
                     T4 
7 (4) 
22 (11) 
126 (63) 
45 (22) 
 
 
 
1.48 (0.87-2.52) 
 
 
 
0.152 
  
Adjuvant therapy      no 
                                  yes 
182 (91) 
18 (9) 
 
1.42 (0.50-4.03) 
 
0.507 
 
 
 
 
Differentiation    Mod-well    
                            Poor 
183 (91) 
17 (9) 
 
2.17 (0.84-5.61) 
 
0.110 
  
Vascular invasion          no 
                                       yes 
Peritoneal involvement  no 
                                       yes 
Margin involvement      no 
                                       yes 
Tumour Perforation       no 
                                      yes 
152 (76) 
48 (24) 
157 (78) 
43 (22) 
186 (92) 
14 (8) 
195 (97) 
5 (3) 
 
2.63 (1.34-5.17) 
 
1.81 (0.90-3.61) 
 
0.84 (0.20-3.50) 
 
4.23 (1.00-17.89) 
 
0.005 
 
0.095 
 
0.811 
 
0.050 
 
 
 
 
Petersen Index    Low Risk 
                            High Risk 
179 (89) 
21 (11) 
 
3.36 (1.52-7.46) 
 
0.003 
 
2.45 (1.08-5.45) 
 
0.032 
Perineural Invasion       no 
                                      yes 
185 (92) 
15 (8) 
 
3.63 (1.59-8.29) 
 
0.002 
 
3.62 (1.48-8.89) 
 
0.005 
Invasive Margin          
  Expanding 
  Infiltrating 
 
121 (61) 
79 (39) 
 
 
1.95 (1.01-3.76) 
 
 
0.046 
 
 
 
 
 
0.407 
Peritumoural Infiltrate    
(Jass criteria)                  
  Cap-like                yes 
  Cap-like                no 
 
 
52 (26) 
148 (74) 
 
 
 
2.00 (0.83-4.80) 
 
 
 
0.122 
 
 
 
 
 
 
 
Peritumoural Infiltrate  
(Klintrup criteria) 
   High grade inflammation 
   Low grade inflammation 
 
 
82 (41) 
118 (59) 
 
 
 
2.65 (1.21-5.82) 
 
 
 
0.015 
 
 
 
2.61(1.19-5.77) 
 
 
 
0.017 
 
Table 2:  The relationship between clinico-pathological variables and cancer specific survival in 
patients with low risk Petersen Index following curative surgery for node-negative colorectal 
cancer. 
 
 
 
Patients 
n=179 (%) 
Univariate Analysis  
Hazard Ratio (95% CI) 
 
P-value 
Multivariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Age  <65 years 
        65-74years 
        >75years 
57 (32) 
63 (35) 
59 (33) 
 
 
2.01 (1.21-3.33) 
 
 
0.005 
 
 
2.31 (1.37-3.89) 
 
 
0.002 
Sex  female 
        Male 
77 (43) 
102 (57) 
 
0.96 (0.45-2.02) 
 
0.907 
 
 
 
 
Number of nodes harvested 
                                 >12 
                                 <12 
 
109 (61) 
70 (39) 
 
 
1.80 (0.86-3.79) 
 
 
0.121 
 
 
  
 
 
 
T Stage         T1 
                     T2 
                     T3 
                     T4 
7 (4) 
22 (12) 
125 (70) 
25 (14) 
 
 
 
1.04 (0.57-1.88) 
 
 
 
0.908 
  
Adjuvant therapy  no 
                              Yes 
166 (93) 
13 (7) 
 
0.46 (0.06-3.40) 
 
0.487 
 
 
 
 
Differentiation     Mod-well   
                             Poor 
165 (92) 
14 (8) 
 
2.51 (0.86-7.32) 
 
0.091 
  
0.198 
Vascular invasion           no 
                                       yes 
Peritoneal involvement  no 
                                       yes 
Margin involvement      no 
                                       yes 
Tumour Perforation       no 
                                       yes 
146 (82) 
33 (18) 
154 (74) 
25 (26) 
176 (93) 
3 (7) 
179 (97) 
0 (3) 
 
1.46 (0.59-3.62) 
 
1.15 (0.44-3.03) 
 
1.87 (0.25-13.94) 
 
 
 
0.409 
 
0.776 
 
0.540 
 
 
  
 
Perineural Invasion        no 
                                       yes 
169 (94) 
10 (6) 
 
3.39 (1.18-9.79) 
 
0.024 
 
3.55 (1.20-10.55) 
 
0.022 
Invasive Margin   
                       Expanding 
                       Infiltrating 
 
111 (62) 
68 (38) 
 
 
2.07 (0.98-4.36) 
 
 
0.055 
 
 
 
 
0.246 
Peritumoural Infiltrate    
(Jass criteria)                  
Cap-like                yes 
Cap-like                no 
 
 
48 (27) 
131 (73) 
 
 
 
2.40 (0.83-6.93) 
 
 
 
0.105 
  
Peritumoural Infiltrate 
(Klintrup criteria) 
   High grade inflammation 
   Low grade inflammation 
 
 
76 (43) 
103 (57) 
 
 
 
2.83 (1.15-6.98) 
 
 
 
0.024 
 
 
 
3.04 (1.22-7.58) 
 
 
 
0.017 
 
 
 
 
 
 
 
 
Table 3:  Inter-relationships between pathological variables in patients with a low risk Petersen Index following potentially curative resection for 
node-negative colon cancer (n=179). 
 
 Node 
sample 
(<12/ >12) 
Diff 
(mod-well/ 
poor) 
VI 
(no/ yes) 
Perit Inv 
(no / yes) 
Margin Inv 
(no / yes) 
Perineur Inv 
(no / yes) 
Tumour 
Margin 
(exp/inf) 
Jass criteria 
(Yes/ No) 
Klintrup 
criteria 
(Yes/ No) 
T stage 
(1/ 2/ 3/ 4) 
 
0.943 
 
0.218 
 
0.993 
 
<0.001 
 
0.868 
 
0.846 
 
0.002 
 
0.001 
 
0.004 
Node sample 
(>12/<12) 
  
0.386 
 
0.124 
 
0.006 
 
0.837 
 
0.545 
 
0.044 
 
0.339 
 
0.017 
Differentiation 
(poor/ mod/well) 
  
 
 
0.310 
 
0.403 
 
0.612 
 
0.141 
 
0.697 
 
0.637 
 
0.975 
Vascular invasion 
(yes/ no ) 
    
0.011 
 
0.408 
 
<0.001 
 
0.170 
 
0.095 
 
0.434 
Perit. involvement 
(yes/ no) 
     
0.483 
 
0.572 
 
0.004 
 
0.022 
 
0.015 
Margin Involved 
(yes/ no) 
     
 
 
0.672 
 
0.867 
 
0.292 
 
0.135 
Perineural  inv. 
(yes/ no) 
       
0.422 
 
0.218 
 
0.140 
Tumour margin 
(exp/ infiltrating) 
       
 
 
0.001 
 
<0.001 
Inflammatory cell 
infiltrate present  
(Jass criteria) 
(yes/ no) 
         
 
 
<0.001 
 
 
 
 
 
 
